Tenderwize
Back to tender search

Radionuclide Generators for Southwest Finland 2027-2028 with Option

Varsinais-Suomen hyvinvointialue·Turku, Finland·Expired · Jul 31, 2026·Open·Supplies
Sign up to saveOpen documents
Structured notice only
Original notice title

Finland – Pharmaceutical products – Varsinais-Suomen hyvinvointialueen 68Ge/68Ga-radionuklidigeneraattoreiden hankinta kaudelle 2027-2028 (mahdollinen optiokausi 2029-2030)

50/100

Opportunity Score

Needs reviewMedium complexity
SuppliesExpired
Why this score?

Opportunity

50 / 100

Complexity

40 / 100

Risk factors

No procurement documents were analyzed. Critical details on technical specifications, delivery terms, payment condition...

Structured data and XML provide different submission deadlines (2026-07-31 vs 2026-08-28). Bidding based on the earlier...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Dec 2028
  • Supply of 68Ge/68Ga radionuclide generators.
  • Delivery to Varsinais-Suomen hyvinvointialue, Finland (FI1C1).
Show full summary

Open tender by Varsinais-Suomen hyvinvointialue for supply of 68Ge/68Ga radionuclide generators for the period 2027-2028 with a possible option for 2029-2030. The tender is conducted electronically via kilpo.fi. The estimated value is not disclosed. There are inconsistencies in EU funding indication and submission deadlines between structured data and XML notice.

Risks

No procurement documents were analyzed. Critical details on technical specifications, delivery terms, payment condition...

Structured data and XML provide different submission deadlines (2026-07-31 vs 2026-08-28). Bidding based on the earlier...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • SMEs are explicitly suitable.
  • Electronic ordering and payment required.

Administrative

  • Tender must be submitted electronically via kilpo.fi.

Requirements may be incomplete.

Award Criteria

Lot 1

Price 50% - method described in tender documents. — 50%Quality 50% - definition and scoring described in tender documents. — 50%

Buyer

Location

Turku, FIN

Identifier

3221065-1

Activity

Health

Lots (1)

LOT-0000

Radionuclide Generators for Southwest Finland 2027-2028 with Option

Supply of 68Ge/68Ga radionuclide generators for the Wellbeing Services County of Southwest Finland. Initial contract period 1.1.2027-31.12.2028 with possible option period 1.1.2029-31.12.2030. Full details in tender documents.

SuppliesEU fundedElectronic submissionSME suitable

Location

FI1C1, Finland

Duration

Dec 2026 - Dec 2028

Category

Pharmaceutical products

Award Criteria

Best price-quality ratio

Deadline

Expired Jul 31, 2026

Procurement Details

Publication date
10 Jun 2026
Languages
Finnish

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
399051-2026

Documents (1)

Procurement document 1

Similar tenders

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.

Dec 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30